1. 3000 Chemo-radiation (CRT) and mutation profile in stage III Non Small Cell Lung Cancer (NSCLC): An analysis of the prognostic value. Issue 3 (September 2015) Authors: Boros, A.; Lacroix, L.; Lacas, B.; Adam, J.; Pignon, J.P.; Caramella, C.; Planchard, D.; Levy, A.; Montpreville, V.; Deutsch, E.; Besse, B.; Pechoux, C. Le Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3025 Prognostic value of PDL1 expression in stage III Non-Small Cell Lung Cancer (NSCLC) treated by chemo-radiotherapy (CRT). (September 2015) Authors: Adam, J.; Boros, A.; Lacas, B.; Lacroix, L.; Pignon, J.P.; Caramella, C.; Planchard, D.; Levy, A.; Besse, B.; Pechoux, C. Le Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3076 Tumor control of advanced pulmonary carcinoid tumors with somatostatin analogs: Experience at Gustave Roussy. (September 2015) Authors: Sullivan, I.; Baudin, E.; Guigay, J.; Scoazec, J.Y.; Leboulleux, S.; Berdelou, A.; Ducreux, M.; Malka, D.; Caramella, C.; Besse, B.; Planchard, D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3081 Molecular Tumor Board (MTB) in non-small cell lung cancers (NSCLC) to optimize targeted therapies: 4 years' experience at Gustave Roussy. (September 2015) Authors: Planchard, D.; Faivre, L.; Sullivan, I.; Kahn-charpy, V.; Lacroix, L.; Auger, N.; Adam, J.; De Montpreville, V. Thomas; Dorfmuller, P.; Pechoux, C. Le; Chevalier, T. Le; Gazzah, A.; Remon, J.; Bescher, G.; Soria, J.C.; Pignon, J.P.; Besse, B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 4P FDG PET derived metabolic tumor volume (MTV) and its transcriptomic correlates as biomarker to predict efficacy of immune checkpoint inhibitors (ICB) alone or in combination with chemotherapy in advanced NSCLC: A multicentric study. (December 2022) Authors: Dall'Olio, F.G.; Garcia, C.A.; Zrafi, W.S.; Fortunati, E.; Bettayeb, A.; Zalcman, G.; Remon Masip, J.; Hendriks, L.; Tagliamento, M.; Bonardel, G.; Helissey, C.; Roelants, V.; Fourquet, A.; Aboubakar, F.; Chaput-Gras, N.; Passiglia, F.; Monnet, I.; Planchard, D.; Barlesi, F.; Besse, B. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience. (September 2016) Authors: Bluthgen, M.V.; Boutros, C.; Fayard, F.; Remon, J.; Planchard, D.; Besse, B. Journal: Lung cancer Issue: Volume 99(2016) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. ASSOCIATION OF LIPI SCORE WITH IMMUNOTHERAPY OUTCOMES IN ELDERLY POPULATION. (November 2019) Authors: Belmaachi, A.; Auclin, E.; Vincent, H.; Varga, A.; Romano, P.Martin; Vuagnat, P.; Pérez, L.Mezquita; Besse, B.; Planchard, D.; Hollebecque, A.; Champiat, S.; Marabelle, A.; Massard, C.; Baldini, C. Journal: Journal of geriatric oncology Issue: Volume 10(2019)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients. (February 2019) Authors: Charrier, M.; Mezquita, L.; Lueza, B.; Dupraz, L.; Planchard, D.; Remon, J.; Caramella, C.; Cassard, L.; Boselli, L.; Reiners, K.S.; Pogge von Strandmann, E.; Rusakiewicz, S.; Ferrara, R.; Duchemann, B.; Naigeon, M.; Pignon, J.P.; Besse, B.; Chaput, N. Journal: European journal of cancer Issue: Volume 108(2019) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EP-1250: Outcome after stereotactic radiotherapy for brain metastasis of lung cancer: a retrospective study. (April 2016) Authors: Grellier Adedjouma, N.; Levy, A.; Suissa, A.; Belkhir, F.; Xu, P.; Martinetti, F.; Planchard, D.; Besse, B.; Le Péchoux, C. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors. (June 2016) Authors: Walter, T.; Planchard, D.; Bouledrak, K.; Scoazec, J.Y.; Souquet, P.J.; Dussol, A.S.; Guigay, J.; Hervieu, V.; Berdelou, A.; Ducreux, M.; Arpin, D.; Lombard-Bohas, C.; Baudin, E. Journal: Lung cancer Issue: Volume 96(2016) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗